Department of Pathology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Translational Medicine, Department of Pathophysiology, Nanjing Medical University, Nanjing, China.
Biochim Biophys Acta Gene Regul Mech. 2019 Sep;1862(9):194412. doi: 10.1016/j.bbagrm.2019.194412. Epub 2019 Jul 26.
Non-alcoholic steatohepatitis (NASH) is one of the most predominant disorders in metabolic syndrome. Induction of pro-inflammatory mediators in hepatocytes exposed to free fatty acids represents a hallmark event during NASH pathogenesis. C-reactive protein (CRP) is a prototypical pro-inflammatory mediator. In the present study, we investigated the mechanism by which megakaryocytic leukemia 1 (MKL1) mediates palmitate (PA) induced CRP transcription in hepatocytes. We report that over-expression of MKL1, but not MKL2, activated the CRP promoter whereas depletion or inhibition of MKL1 repressed the CRP promoter. MKL1 potentiated the induction of the CRP promoter activity by PA treatment. Importantly, MKL1 knockdown by siRNA or pharmaceutical inhibition by CCG-1423 attenuated the induction of endogenous CRP expression in hepatocytes. Similarly, primary hepatocytes isolated from wild type (WT) mice produced more CRP than those isolated from MKL1 deficient (KO) mice when stimulated with PA. Mechanistically, the sequence-specific transcription factor CCAAT-enhancer-binding protein (C/EBPβ) interacted with MKL1 and recruited MKL1 to activate CRP transcription. Reciprocally, MKL1 modulated C/EBPβ activity by recruiting the chromatin remodeling protein BRG1 to the CRP promoter to alter histone modifications. In conclusion, our data delineate a novel epigenetic mechanism underlying augmented hepatic inflammation during NASH pathogenesis.
非酒精性脂肪性肝炎(NASH)是代谢综合征中最常见的疾病之一。在 NASH 发病机制中,暴露于游离脂肪酸的肝细胞中促炎介质的诱导是一个标志性事件。C 反应蛋白(CRP)是一种典型的促炎介质。在本研究中,我们研究了巨核细胞白血病 1(MKL1)介导游离脂肪酸诱导的肝细胞 CRP 转录的机制。我们报告说,MKL1 的过表达而非 MKL2 激活了 CRP 启动子,而 MKL1 的耗竭或抑制则抑制了 CRP 启动子。MKL1 增强了 PA 处理诱导的 CRP 启动子活性。重要的是,siRNA 敲低 MKL1 或 CCG-1423 药物抑制减弱了肝细胞中内源性 CRP 表达的诱导。同样,当用 PA 刺激时,来自野生型(WT)小鼠的原代肝细胞比来自 MKL1 缺失(KO)小鼠的原代肝细胞产生更多的 CRP。在机制上,序列特异性转录因子 CCAAT 增强子结合蛋白(C/EBPβ)与 MKL1 相互作用,并募集 MKL1 激活 CRP 转录。反过来,MKL1 通过募集染色质重塑蛋白 BRG1 到 CRP 启动子来改变组蛋白修饰,从而调节 C/EBPβ 的活性。总之,我们的数据描绘了 NASH 发病机制中肝炎症增强的新的表观遗传机制。